Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Top Stories > SCOTTISH EQUITY PARTNERS ANNOUNCES INVESTMENT IN DOTMATICS

SCOTTISH EQUITY PARTNERS ANNOUNCES INVESTMENT IN DOTMATICS

Published by Gbaf News

Posted on November 3, 2017

3 min read

Last updated: January 21, 2026

Opposition lawmakers in Ukraine advocating for energy minister's removal - Global Banking & Finance Review — An image depicting opposition lawmakers in Ukraine pushing to oust the energy minister, reflecting the political climate that can influence the coil coatings market's growth and trends in the construction industry.

Scottish Equity Partners (SEP) completes a significant investment in Dotmatics. The company, founded in 2005, is a leading global scientific informatics software provider delivering enterprise solutions tailored to the modern, highly collaborative and mobile scientific environments. Dotmatics provides solutions for pharmaceutical, biotechnology, academia, food and beverage, oil and gas, and agrochemical industries. The funding will enable Dotmatics to continue its investment into product innovation and customer success, as well as to strengthen operations in each of its key geographies.

Dotmatics’ comprehensive solutions include tools for knowledge management, data storage, enterprise querying and reporting, data analysis and visualisation. Headquartered in the UK, Dotmatics is one of the fastest growing global informatics companies and currently employs more than 100 people including chemists, biologists and software engineers across Europe, USA and Asia Pacific.

The investment deal was led by SEP partners Keith Davidson and Jan Rutherford. Keith Davidson said, “Dotmatics is a fast growing and capital efficient SaaS business, with an excellent reputation in the scientific research informatics market. The company has a strong focus on innovation and providing customers with first class scientific solutions and support. We have watched the company expand its customer base significantly over the course of the last few years and look forward to supporting its future growth plans.”

Stephen Gallagher, CEO of Dotmatics, commented, “We have grown rapidly and organically since inception and are pleased to have secured SEP as investors given the firm’s considerable software and health sector experience and their record of scaling companies. The funding will enable us to continue our aggressive trajectory in providing chemistry solutions, further expansion into biologics and increase our investment into customer support through strategic hires in application science product development and professional services.”

Scottish Equity Partners (SEP) completes a significant investment in Dotmatics. The company, founded in 2005, is a leading global scientific informatics software provider delivering enterprise solutions tailored to the modern, highly collaborative and mobile scientific environments. Dotmatics provides solutions for pharmaceutical, biotechnology, academia, food and beverage, oil and gas, and agrochemical industries. The funding will enable Dotmatics to continue its investment into product innovation and customer success, as well as to strengthen operations in each of its key geographies.

Dotmatics’ comprehensive solutions include tools for knowledge management, data storage, enterprise querying and reporting, data analysis and visualisation. Headquartered in the UK, Dotmatics is one of the fastest growing global informatics companies and currently employs more than 100 people including chemists, biologists and software engineers across Europe, USA and Asia Pacific.

The investment deal was led by SEP partners Keith Davidson and Jan Rutherford. Keith Davidson said, “Dotmatics is a fast growing and capital efficient SaaS business, with an excellent reputation in the scientific research informatics market. The company has a strong focus on innovation and providing customers with first class scientific solutions and support. We have watched the company expand its customer base significantly over the course of the last few years and look forward to supporting its future growth plans.”

Stephen Gallagher, CEO of Dotmatics, commented, “We have grown rapidly and organically since inception and are pleased to have secured SEP as investors given the firm’s considerable software and health sector experience and their record of scaling companies. The funding will enable us to continue our aggressive trajectory in providing chemistry solutions, further expansion into biologics and increase our investment into customer support through strategic hires in application science product development and professional services.”